5.4. summary evidence recommendations diagnostic assessment rcc. summary evidencelecontrast enhanced multi-phasic ct high sensitivity specificity characterisation detection rcc, invasion, tumour thrombus mrcc.2amagnetic resonance imaging slightly higher sensitivity specificity small cystic renal masses tumour thrombi compared ct.2acontrast enhanced us high sensitivity specificity characterisation renal masses.2arenal mass biopsies associated reduced overtreatment benign masses offers patients additional information (i.e. grade, subtype) informed decision regarding optimal management.3ultrasound, power-doppler us positron-emission tomography ct low sensitivity specificity detection characterisation rcc.2a recommendationsstrength ratinguse multi-phasic contrast-enhanced computed tomography (ct) abdomen chest diagnosis staging renal tumours.strongomit chest ct patients incidentally noted ct1a disease due low risk lung metastases cohort.weakuse magnetic resonance imaging (mri) better evaluate venous involvement, reduce radiation avoid intravenous ct contrast medium.weakuse non-ionising modalities, including mri contrast-enhanced ultrasound, characterisation small renal masses, tumour thrombus differentiation unclear renal masses, case results contrast-enhanced ct indeterminate.strongoffer brain ct/mri metastatic patients systemic therapy cytoreductive nephrectomy considered.weakdo routinely use bone scan and/or positron-emission tomography ct staging renal cell carcinoma.weakperform renal tumour biopsy ablative therapy systemic therapy without previous pathology.strongperform percutaneous biopsy select patients considering active surveillance.weakuse coaxial technique performing renal tumour biopsy.strongdo perform renal tumour biopsy cystic renal masses unless significant solid component visible imaging.stronguse core biopsy technique rather fine needle aspiration histological characterisation solid renal tumours.strong